Burning Rock Biotech (BNR) Cash from Investing Activities (2020 - 2025)
Historic Cash from Investing Activities for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$386000.0.
- Burning Rock Biotech's Cash from Investing Activities rose 2475.63% to -$386000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$893000.0, marking a year-over-year increase of 293.48%. This contributed to the annual value of -$604000.0 for FY2024, which is 5385.79% up from last year.
- Latest data reveals that Burning Rock Biotech reported Cash from Investing Activities of -$386000.0 as of Q3 2025, which was up 2475.63% from -$185000.0 recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Cash from Investing Activities registered a high of $44.0 million during Q1 2021, and its lowest value of -$11.2 million during Q3 2021.
- In the last 5 years, Burning Rock Biotech's Cash from Investing Activities had a median value of -$386000.0 in 2025 and averaged $407842.1.
- In the last 5 years, Burning Rock Biotech's Cash from Investing Activities skyrocketed by 14386.89% in 2022 and then plummeted by 49677.42% in 2025.
- Quarter analysis of 5 years shows Burning Rock Biotech's Cash from Investing Activities stood at -$10.5 million in 2021, then skyrocketed by 93.05% to -$730000.0 in 2022, then surged by 93.7% to -$46000.0 in 2023, then plummeted by 141.3% to -$111000.0 in 2024, then plummeted by 247.75% to -$386000.0 in 2025.
- Its Cash from Investing Activities was -$386000.0 in Q3 2025, compared to -$185000.0 in Q2 2025 and -$211000.0 in Q1 2025.